PANTHERx® Rare Pharmacy announces that it has been selected by Harmony Biosciences, LLC (Harmony) to distribute WAKIX® (pitolisant). PANTHERx is one of a select few specialty pharmacies providing nationwide access to the medication. “We are excited to be a part of the WAKIX® distribution network as we work with Harmony,” said Dr. Gordon Vanscoy, Chairman […]

    September 6, 2019 – Pittsburgh, PA PANTHERx Rare Pharmacy has issued a Request for Information (RFI) for a Pharmacy Management System (PMS) that would replace the current digital operational environment and database structure. The RFI specifically seeks to provide PANTHERx Rare with the understanding of available marketplace solutions to enable pharmaceutical services in […]

PANTHERx Rare Pharmacy announces that it has, for a 4th time, been named to the Inc. 5000 list, celebrating the fastest-growing private companies in America. PANTHERx is being recognized on this prestigious national list as the 268th fastest growing company overall and the 26th fastest growing company in Health. Regionally, PANTHERx is the #6 fastest […]

Click here to read the full press release.   As the medical community has learned more about rare diseases and the complex medications and models used to treat rare disease patients, rare pharmacy has emerged as a growing sub-section of specialty pharmacy with its own unique domain of knowledge and skills. With this in mind, […]

PANTHERx Specialty Pharmacy, the industry leading independent national specialty pharmacy, has been selected by Paratek Pharmaceuticals, Inc. as a limited pharmacy network provider of its new once-daily oral antibiotic, Nuzyra™ (omadacycline). Nuzyra™ is a tetracycline class antibacterial approved to treat adults with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). […]